Dietary Modulation of Intestinal Microbiota: Future Opportunities in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis
Authors:
Open Access
- 16 April 2019
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 10, 740
Abstract
Multiple sclerosis (MS) is an autoimmune disease that affects the functioning of the central nervous system (CNS). Recent studies on MS and its animal model, experimental autoimmune encephalomyelitis (EAE), have shown that the composition and abundance of microbes in the intestinal microbiota are an environmental risk factor for the development of MS and EAE. Changes in certain microbial populations in the gastrointestinal tract can cause MS in humans, but MS inflammation can be reduced or even prevented by introducing other commensal microbes that produce beneficial metabolites. Other risk factors for MS include the presence of an altered gut physiology and the interaction between the intestinal microbiota and the immune system. Metabolites including short-chain fatty acids (SCFAs), such as butyrate, are the primary signaling molecules produced by the intestinal microbiota that interact with the host immune system, suggesting an association between MS pathophysiology and gut microbiota. In addition, several host microRNAs present in the gut have been found to interact with the intestinal microbial community, these interactions may indirectly affect the neurological system. Increasing evidence has shown that regulation of the intestinal microbiota is an important approach for reducing MS inflammation. Thus, here we review the use of diet to alter the gut microbiota and its application in the treatment and prevention of MS.Keywords
Funding Information
- National Natural Science Foundation of China (81501299)
This publication has 77 references indexed in Scilit:
- An intestinal commensal symbiosis factor controls neuroinflammation via TLR2-mediated CD39 signallingNature Communications, 2014
- A commensal bacterial product elicits and modulates migratory capacity of CD39+CD4 T regulatory subsets in the suppression of neuroinflammationGut Microbes, 2014
- Microbiota-Gut-Brain Axis and Cognitive Function2014
- The HPA – Immune Axis and the Immunomodulatory Actions of Glucocorticoids in the BrainFrontiers in Immunology, 2014
- Environmental factors in multiple sclerosisExpert Review of Neurotherapeutics, 2013
- A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitisGut, 2013
- Environmental factors and their regulation of immunity in multiple sclerosisJournal of the Neurological Sciences, 2013
- Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelinationNature, 2011
- A polysaccharide from the human commensal Bacteroides fragilis protects against CNS demyelinating diseaseMucosal Immunology, 2010
- Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitisProceedings of the National Academy of Sciences, 2010